⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19221730 | 0.76 | — | — | |
| SCHEMBL21443879 | 0.74 | — | — | |
| SCHEMBL1196124 | 0.70 | — | — | |
| SCHEMBL27483712 | 0.68 | — | — | |
| SCHEMBL27519272 | 0.68 | — | — | |
| SCHEMBL27498624 | 0.68 | — | — | |
| SCHEMBL27500153 | 0.68 | — | — | |
| SCHEMBL27481533 | 0.68 | — | — | |
| SCHEMBL27481534 | 0.68 | — | — | |
| SCHEMBL27483713 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117942284-A | Antibacterial skin-friendly wet tissue | 安徽创意家生物科技有限公司 | 2024-04-30 | — | — | CN | claimed |
| US-20250114380-A1 | SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-04-10 | — | — | US | disclosed |
| CN-117942284-A | Antibacterial skin-friendly wet tissue | 安徽创意家生物科技有限公司 | 2024-04-30 | — | — | CN | disclosed |
| EP-3684352-A1 | VANADYL AND VANADATE FOR USE IN REDUCING STRESS -INDUCED METABOLIC DERANGEMENT | CFM Pharma Holding BV (NL) | 2020-07-29 | — | — | EP | disclosed |
| WO-2019059770-A1 | VANADYL AND VANADATE FOR USE IN REDUCING STRESS -INDUCED METABOLIC DERANGEMENT | CFM PHARMA HOLDING B.V. (NL) | 2019-03-28 | — | — | WO | disclosed |
| US-20190002919-A1 | In Vivo Methods for Enhancing Bioenergetic Status in Female Germ Cells | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2019-01-03 | — | — | US | disclosed |
| EP-2875359-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS | Charles R Drew University of Medicine and Science (US) | 2015-05-27 | — | — | EP | disclosed |
| EP-2726601-A1 | COMPOSITIONS AND METHODS FOR ENHANCING BIOENERGETIC STATUS IN FEMALE GERM CELLS | The General Hospital Corporation (US) | 2014-05-07 | — | — | EP | disclosed |
| WO-2013149258-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS | Charles Drew University of Medicine and Science (US) | 2013-10-03 | — | — | WO | disclosed |
| EP-2598208-A2 | NEW USES | Evocutis plc (GB) | 2013-06-05 | — | — | EP | disclosed |
| WO-2013002880-A1 | COMPOSITIONS AND METHODS FOR ENHANCING BIOENERGETIC STATUS IN FEMALE GERM CELLS | THE GENERAL HOSPITAL CORPORATION (US) | 2013-01-03 | — | — | WO | disclosed |
| EP-2454271-A2 | PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE | The Regents of the University of California (US) | 2012-05-23 | — | — | EP | disclosed |
| WO-2012013967-A2 | NEW USES | SYNTOPIX GROUP PLC (GB) | 2012-02-02 | — | — | WO | disclosed |
| WO-2011008992-A2 | PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-20 | — | — | WO | disclosed |